Your browser doesn't support javascript.
loading
Comparative outcomes and prognostic indicators in adrenalectomy for adrenal metastasis.
Kwak, JungHak; Bae, Hye Lim; Jung, Younghoon; Choi, Jaebong; Hwang, Hyeonuk; Kim, Jung Hee; Kim, Su-Jin; Lee, Kyu Eun.
Afiliação
  • Kwak J; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Bae HL; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • Jung Y; Division of Endocrine Surgery, Department of Surgery, Gibbeum Hospital, Seoul, Korea.
  • Choi J; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Hwang H; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JH; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Kim SJ; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
  • Lee KE; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Surg Endosc ; 38(4): 1884-1893, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38316662
ABSTRACT

PURPOSE:

The indications for adrenalectomy and feasibility of laparoscopic adrenalectomy for adrenal metastasis are controversial. This study aimed to compare the surgical outcomes between open adrenalectomy (OA) and laparoscopic adrenalectomy (LA) and to evaluate the prognostic factors for oncological outcomes of adrenal metastasis. MATERIALS AND

METHODS:

We conducted a retrospective chart review of 141 consecutive patients who underwent adrenalectomy for adrenal metastasis at Seoul National University Hospital from April 2005 to February 2021. Surgical and oncological outcomes were compared between OA and LA.

RESULTS:

OA was performed in 95 (67.4%) patients, and 46 (32.6%) patients underwent LA. Among the patients who underwent adrenalectomy without adjacent organ resection for adrenal tumors less than 8 cm, LA was associated with a shorter operation time (100.1 ± 48.8 vs. 158.6 ± 81.2, P = 0.001), less blood loss (94.8 ± 93.8 vs. 566.8 ± 1156.0, P = 0.034), and a shorter hospital stay (3.7 ± 1.3 vs. 6.9 ± 5.8, P = 0.003). For locoregional recurrence-free survival (LRRFS), on multivariate analysis, a positive pathological margin (hazard ratio [HR] 5.777, P = 0.002), disease activity at the primary site (HR 6.497, P = 0.005), other metastases (HR 4.154, P = 0.015), and a relatively larger tumor size (HR 1.198, P = 0.018) were significantly associated with poor LRRFS. Multivariate analysis indicated that metachronous metastasis (HR 0.51, P = 0.032) was associated with a longer overall survival (OS), whereas a positive pathological margin (HR 2.40, P = 0.017), metastases to other organs (HR 2.08, P = 0.025), and a relatively larger tumor size (HR 1.11, P = 0.046) were associated with a shorter OS.

CONCLUSIONS:

LA is a feasible treatment option for adrenal metastasis in selected patients. The pathological margin, metastases to other organs, and tumor size should be considered in adrenalectomy for adrenal metastasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Laparoscopia / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Laparoscopia / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article